These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24689351)

  • 21. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy.
    Malaguarnera M; Gargante MP; Malaguarnera G; Salmeri M; Mastrojeni S; Rampello L; Pennisi G; Li Volti G; Galvano F
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):199-206. PubMed ID: 19730107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management options for minimal hepatic encephalopathy.
    Bajaj JS
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):785-90. PubMed ID: 19090738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy of portal-systemic encephalopathy: the practical and the promising.
    Weber FL
    Gastroenterology; 1981 Jul; 81(1):174-7. PubMed ID: 7239116
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of administration of Escherichia coli Nissle (Mutaflor) on intestinal colonisation, endo-toxemia, liver function and minimal hepatic encephalopathy in patients with liver cirrhosis].
    Lata J; Juránková J; Príbramská V; Fric P; Senkyrík M; Díte P; Kroupa R
    Vnitr Lek; 2006 Mar; 52(3):215-9. PubMed ID: 16722152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Commentary: Probing probiotics in cirrhosis--a template for future studies?
    Quigley EM
    Aliment Pharmacol Ther; 2014 Jun; 39(11):1334-5. PubMed ID: 24803249
    [No Abstract]   [Full Text] [Related]  

  • 26. Commentary: Probing probiotics in cirrhosis--a template for future studies? Author's reply.
    Bajaj JS
    Aliment Pharmacol Ther; 2014 Jun; 39(11):1335-6. PubMed ID: 24803250
    [No Abstract]   [Full Text] [Related]  

  • 27. The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review.
    Viramontes Hörner D; Avery A; Stow R
    J Clin Gastroenterol; 2017 Apr; 51(4):312-323. PubMed ID: 28059938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy.
    Saji S; Kumar S; Thomas V
    Trop Gastroenterol; 2011; 32(2):128-32. PubMed ID: 21922877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis.
    Zhao LN; Yu T; Lan SY; Hou JT; Zhang ZZ; Wang SS; Liu FB
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):674-82. PubMed ID: 25956487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What type of probiotic was used?
    Montagnese S; Amodio P; Angeli P
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):471-2. PubMed ID: 22395181
    [No Abstract]   [Full Text] [Related]  

  • 31. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial.
    Lunia MK; Sharma BC; Sharma P; Sachdeva S; Srivastava S
    Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1003-8.e1. PubMed ID: 24246768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.
    Tromm A; Griga T; Greving I; Hilden H; Hüppe D; Schwegler U; Micklefield GH; May B
    Hepatogastroenterology; 2000; 47(32):473-7. PubMed ID: 10791216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota modulation in cirrhosis: a new frontier in hepatology.
    Karakan T
    Turk J Gastroenterol; 2014 Feb; 25(1):126. PubMed ID: 24918152
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of Overt Hepatic Encephalopathy.
    Sussman NL
    Clin Liver Dis; 2015 Aug; 19(3):551-63. PubMed ID: 26195208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of necrotizing enterocolitis with probiotics.
    Kliegman RM; Willoughby RE
    Pediatrics; 2005 Jan; 115(1):171-2. PubMed ID: 15629995
    [No Abstract]   [Full Text] [Related]  

  • 36. Current and emerging strategies for treating hepatic encephalopathy.
    Foster KJ; Lin S; Turck CJ
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):341-50. PubMed ID: 20691385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacotherapy of hepatic encephalopathy in cirrhosis.
    Romero-Gómez M
    Expert Opin Pharmacother; 2010 Jun; 11(8):1317-27. PubMed ID: 20384539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical research on microecologic treatment combined enteral nutrition for hepatic encephalopathy].
    Dai G; Wu D; Lian J; Ma H; Jiang B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Dec; 35(12):1392-5. PubMed ID: 25623462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complex therapy of chronic hepatic encephalopathy supplemented with probiotic: comparison of two studies].
    Boca M; Vyskocil M; Mikulecký M; Ebringer L; Kolibás E; Kratochvíl'ová H; Buzgová D
    Cas Lek Cesk; 2004; 143(5):324-8. PubMed ID: 15305769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy for the treatment and prevention of hepatic encephalopathy.
    Mohammad RA; Regal RE; Alaniz C
    Ann Pharmacother; 2012 Nov; 46(11):1559-63. PubMed ID: 23092866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.